Medical network on February 22 - shocking news! 90% of the province medicine circulation share, only to several large companies; Other nearly 800 vendors, only for the remaining 10%.
▍ hubei 55.3 billion circulation market, only to top drug manufacturers across the country
On February 21st, in hubei province reform office issued the "much starker choices-and graver consequences-in" deepening the reform of medical health system planning of hubei province (hereinafter referred to as planning) "(draft). In "we will deepen reform of the medicine circulation system" link, hubei health do a series of measures, will bring the currency market upheaval. Main points are as follows:
To speed up the construction of drug circulation a unified and open break local protection; The development of medicine circulation enterprise merger and reorganization, the third party logistics and cold chain logistics; Promote the retail pharmacies classified management, increase the rate of retail chain; Strive for to 2020, establish the ex-factory price of basic information traceability system, pharmaceutical wholesale enterprises with annual sales accounted for more than 90% of the total amount of wholesale markets.
The most notable is the "pharmaceutical wholesale enterprises annual sales accounted for more than 90% of the total amount of wholesale market". How big is the share? In 2015, according to the office of business data, medicine circulation industry of hubei province total sales of 61.519 billion yuan. Achievement is 55.358 billion, 90% share of the big cake, is the company?
▍ 800 drug, only 800 market, who can live?
In June 2016, the ministry of commerce issued "the top 2015 pharmaceutical wholesale enterprises list", besides kyushu tong, happy people medicine, according to rough statistics, in a subsidiary company in hubei, or these familiar names: state-controlled, China resources, medicine, medicine, south medicine, chongqing medical and pharmaceutical giants such as east China.
Hubei local drug, not a landing. And, according to department of commerce of hubei province by the end of 2015, in hubei province in the drug supply quality management norms "(GSP) certificates and wholesale business license of enterprise with 757, if you count increment of nearly two years, this figure may be closer to 800.
According to the hubei province of the planning, a cruel fact is that nearly 800 drug, going for the big points of the remaining 10% share, only 6 billion of the market. On average, less than tens of millions of each drug, objective, said that it's difficult to make any sales to survive a druggist.
▍ big small and medium-sized manufacturers and exits, the best result is acquired
This is typical of openings, the besieged in many manufacturers in the small pond, what will happen next, obvious - is going to be a rat race. Don't have to wait until the dust settles, each industry insiders believe that will not hesitate to make judgment: a lot of medicine chamber of commerce in the battle, dim and leave.
Share so much, can only feed a few winners, predictably, druggist populations will collapse. Or bankruptcy, or active log off, or being the top enterprise m&a.
In fact, look at the policy, whether it is promulgated by the state council concerning the further reform and improve the use policy for producing and distributing medicines of several opinions, or for your hubei health reform in the "planning" mentioned "push drugs circulation enterprise merger and reorganization", accurately demonstrate the position: drug companies don't need so many.
In under the guidance of the overall program of the state council, hubei has made the action, believe the other provinces to respond quickly. Look, begin from 2017, the currency market will be a big feast, small and medium-sized manufacturers and can only be drifting away.
In addition, hubei health office said the consultation suggestion "planning" for society, the deadline is on February 24, 2017, 17, Suggestions can be sent to the provincial health office email account. Still have 3 days time.
Attached: "much starker choices-and graver consequences-in" deepening the reform of medical health system planning of hubei province (draft)
(note: there are more than 20000 words, the original for the convenience of reading, only keep associated with pharmaceutical industry's largest content)
"Much starker choices-and graver consequences-in" period is decisive stage in our country to build a well-off society in an all-round way, also is a key period to establish and perfect the system of basic medical and health care. For comprehensively deepen medical health system reform, to promote healthy construction of hubei province, according to the "much starker choices-and graver consequences-in" deepening the reform of medical health system planning ", "hubei province thirteenth five-year plan for national economic and social development program, etc., to compile the planning.
A, planning background (slightly)
Second, the guiding ideology, basic principles and main goal (abbreviated)
Third, the key task
(4) establish a standardized and orderly drug supply security system. Implementation of pharmaceutical production, circulation, use full process reform, adjust the benefit drive mechanism, break with medicine cure, to promote all kinds of comprehensive medical institutions at all levels, priority use of basic drugs, to carry out the national drug policy, straighten out the drug prices, promote medicine industry structure adjustment and transformation and upgrading, to ensure drug is safe and effective, reasonable price, adequate supply.
1. We will deepen reform of the drug supply field (abbreviated)
2. We will deepen reform of the medicine circulation system. Increase the intensity of medicines and chemical reagents, consumable materials circulation industry structure adjustment, guide the supply capacity equilibrium configuration, speed up the construction of drug circulation and unified open, competitive and orderly market and break local protectionism and form a new modern circulation system. Pushing drugs circulation enterprise merger and reorganization and integration pharmaceutical trading enterprises, warehousing and transportation resources, speed up the development of pharmaceutical logistics, encourage regional drug distribution of urban and rural integration. Promote the construction of circulation enterprises to smart medical service transformation, and improve the supply chain integration system and support circulation enterprises to carry out service supply chain upstream and downstream. Application of current big data, develop value-added service depth and breadth, guide the industry development. Encourage the development of green medicine logistics, the development of the third party logistics and cold chain logistics. Support medicines and chemical reagents, consumable retail enterprise in pluralism, differential operation. Popularization and application of modern logistics management and technology, standardizing medical electrical business development, improve the modern traditional Chinese medicinal materials circulation network and tracing system, promote the adjustment of industry structure, enhance the transparency and efficiency of trade. Promote the retail pharmacies classified management, improve the rate of retail chain. Strive for to 2020, establish the ex-factory price of basic information traceability system, pharmaceutical wholesale enterprises with annual sales accounted for more than 90% of the total amount of wholesale markets.
3. Improve the system of medical disposable materials centralized purchasing drugs and high value. (abbreviated)
4. Cement improve the system of basic drugs. (abbreviated)
5. The implementation of the national drug policy. (abbreviated)
Four, safeguard measures (slightly)
|
